2016
DOI: 10.1200/jco.2015.64.8741
|View full text |Cite
|
Sign up to set email alerts
|

Default Options: Opportunities to Improve Quality and Value in Oncology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
1

Year Published

2017
2017
2021
2021

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 64 publications
0
11
1
Order By: Relevance
“…Development, testing, and scaling of strategies to achieve this goal, such as default options, audit and feedback and patient engagement, is warranted. 6 This study has limitations. Because the Centers for Medicare & Medicaid Services data set is missing cancer stage and radiation field, these results underestimate the absolute proportion of beneficiaries receiving shorter regimens.…”
Section: Discussionmentioning
confidence: 92%
“…Development, testing, and scaling of strategies to achieve this goal, such as default options, audit and feedback and patient engagement, is warranted. 6 This study has limitations. Because the Centers for Medicare & Medicaid Services data set is missing cancer stage and radiation field, these results underestimate the absolute proportion of beneficiaries receiving shorter regimens.…”
Section: Discussionmentioning
confidence: 92%
“… 12 Although attractive, these minimally intrusive interventions may yield only modest behavioral changes. 21 More intrusive strategies such as financial incentives 19 or default options 22 might have a greater effect. 20 Alternatively, our modest BS reduction could reflect the limitations of a one-time intervention.…”
Section: Discussionmentioning
confidence: 99%
“…There is evidence to support the hypothesis that stromatous components of malignant tumors stimulate growth and prolifera-tion of malignant components of invasive tumors 2 ; higher stromal content, referred to as high tumor-stroma proportion, has been associated with worse prognosis in many epithelial cancers. [3][4][5] We report the results of a prospective observational study examining tumor-stroma proportion as a predictive biomarker of chemoresistance in women diagnosed with ovarian cancer.…”
Section: Tumor-stroma Proportion As a Predictive Biomarker Of Resistamentioning
confidence: 99%
“…Default options, which leverage insights from behavioral economics, can change physician behavior but have focused less on deadoption of unnecessary care. 3,4 We conducted a stepped-wedge cluster randomized clinical trial to test the effectiveness of introducing a default imaging order in the electronic health record (EHR) vs usual practice to reduce unnecessary daily imaging during palliative radiotherapy.…”
mentioning
confidence: 99%